The Validation of New Photographic Technology for Assessing Skin Lesions
Validation of New Photographic Technology for Assessing Skin Lesions
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this study is to determine the validity of a new photographic technology in a dermatologic setting. The digital picture uses high levels of resolution to look at skin biopsy lesions. These photos will be compared to current standard-of-care with hematoxylin and eosin histologic analysis by board-certified dermatologists.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedFirst Submitted
Initial submission to the registry
October 18, 2024
CompletedFirst Posted
Study publicly available on registry
October 29, 2024
CompletedFebruary 6, 2025
February 1, 2025
10 months
October 18, 2024
February 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of matching dermatologic diagnoses from photography to biopsied lesions.
A group of board-certified dermatologists will evaluate the standard digital vs. enhanced digital photograph of the lesion to compare the accuracy of diagnoses to the pathology report, with pathology serving as the gold standard.
At time of biopsy procedure of the lesion.
Eligibility Criteria
Wright State Physicians Dermatology Clinic
You may qualify if:
- Adult patients ages 18 and older.
- Able to comprehend procedures, risks, and informed consent.
- Have a skin lesion the practitioner believes, and subject agrees, should be biopsied.
- Lesion on a non-revealing part of the body (none on areas that would be recognizable, nor on groin nor breasts).
- Willingness of subject to share the results of the biopsy pathology.
You may not qualify if:
- Lesion on a revealing part of body.
- Unable to understand the procedures, informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wright State Physicians
Fairborn, Ohio, 45324, United States
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2024
First Posted
October 29, 2024
Study Start
February 15, 2023
Primary Completion
December 20, 2023
Study Completion
December 20, 2023
Last Updated
February 6, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share